Consistently, there were also significantly decreased BCL2 expression level in WHSC1-knockdown xenografted tumor tissue compared with control xenografted tumor as assessed by immunohistochemistry and Western blot (Fig. 5c, d). The gene discussed is NSD2; the disease is neoplasm.